- Tumors689
- Pathology555
- Pathologic Processes546
- Nervous System Diseases476
- Nervous System Disorders450
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors689
- Pathology555
- Pathologic Processes546
- Nervous System Diseases476
- Nervous System Disorders450
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- HER2 positive
- EGFR negative
- KRAS positive
- PR positive
- ALK negative
- EGFR positive
- BRAF positive
- ER negative
- PR negative
- PD-L1 negative
- BRAF negative
- BRCA1 positive
- ROS1 negative
- BRCA2 positive
- p16 positive
- HLA positive
- ALK positive
- CD20 positive
- MET positive
- PIK3CA positive
- ROS1 positive
- HR positive
- PALB2 positive
- TP53 positive
- p16 negative
- HLA-A positive
- IDH negative
- MET negative
- MYC positive
- RET positive
- Anti-dsDNA positive
- BCR-ABL1 positive
- HBsAg positive
- NRAS positive
- RET negative
- TP53 negative
- ABCA4 positive
- ANA positive
- Bcl2 positive
- CCND1 positive
- HLA negative
- HLA-A negative
- HPV negative
- IDH positive
- KRAS negative
- MSS positive
- NTRK negative
- NTRK positive
- RAS positive
- RB1 negative
- RB1 positive
- dMMR positive
- APP positive
- BCL6 positive
- BRCA positive
- BRCA1 negative
- BRCA2 negative
- CFTR positive
- COL7A1 positive
- FMR1 positive
- MDM2 positive
- MSI-H positive
- NF1 positive
- PSEN1 positive
- PSEN2 positive
- PTEN positive
- Philadelphia chromosome positive
- RF positive
- RHO positive
- Ras negative
- TROP2 negative
- TROP2 positive
- ctDNA positive
- pMMR positive
- 11q negative
- 11q positive
- AKT negative
- ALPL positive
- ATM positive
- Aβ1-42 positive
- C5 positive
- CLDN18.2 positive
- DLL3 positive
- DMD positive
- EBV positive
- FOXO1 fusion negative
- GRN positive
- HEXA positive
- HEXB positive
- HPV positive
- HPV16 positive
- HRAS positive
- IGHV positive
- JAK2 positive
- KIT positive
- MGMT negative
- MGMT positive
- MLH1 positive
- MMR positive
- MSH2 positive
- MSH6 positive
- MSI-H negative
- NF2 positive
- NRAS negative
- PDE6A positive
- PDE6B positive
- PIK3CD positive
- PIK3R1 positive
- PMM2 positive
- PMS2 positive
- PTCH1 positive
- PTEN negative
- PiZZ positive
- SPINK5 positive
- T790M positive
- TTR positive
- anti-PLA2R positive
- anti-Ro autoantibodies positive
- anti-Ro/SSA positive
- anti-Sm positive
- anti-Smith positive
- dMMR negative
- t(11;14) positive
- 12 negative
- 12 positive
- 13q negative
- 13q positive
- 16p11.2 deletion positive
- 17p negative
- 17p positive
- 19q negative
- 19q positive
- 1p negative
- 1p positive
- 1p/19q co-deletion positive
- 1p/19q loss positive
- 1p36 deletion positive
- 46 XX karyotype positive
- 5q SMA positive
- 5q-autosomal recessive SMA positive
- AAVrh74 antibody titers negative
- ABL-class fusion positive
- ABL-class fusions positive
- ABO negative
- ABO positive
- AChR positive
- AChR-Ab positive
- ADAMTS-13 negative
- ADAMTS-13 positive
- AFP positive
- AKT positive
- AKT1 positive
- APOL1 positive
- Acetylcholine receptor antibody positive
- Anti-CCP-2 positive
- Anti-HBc IgM negative
- Anti-Ro/SS-A positive
- Anti-SSA (Ro) positive
- Anti-SSB (La) positive
- Anti-Smith antibodies positive
- Antinuclear antibody positive
- Aβ1-40 positive
- Aβ1-42/Aβ1-40 ratio positive
- B7-H6 positive
- BCR-ABL1 e13a2 positive
- BCR-ABL1 e14a2 positive
- BCR-ABL1 fusion positive
- BCR-ABL1IS positive
- BTK-C481 positive
- C1-INH functional activity positive
- C1-INH positive
- C10orf2 positive
- C4 antigen level positive
- C5 p.Arg885Cys positive
- C5 p.Arg885His positive
- C9orf72 positive
- CAG expansion positive
- CAG repeat in HTT positive
- CASR positive
- CCND2 positive
- CCND3 positive
- CCNE1 positive
- CD123 positive
- CD19 positive
- CD25 positive
- CD30 negative
- CD30 positive
- CD4 count negative
- CD4 count positive
- CD4 negative
- CD4 positive
- CD5 positive
- CDK4 positive
- CDK6 positive
- CNG negative
- CNG positive
- COL1A1 positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Therapy (except reconstruction)
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Biologic Anti-Neoplastic Agent
- CD4+ > 350 cells/microliter for at least twelve months
- Cancer-Directed Surgery
- Cellular Therapies for ALS
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
2975 trials
1
2
3
…50